Literature DB >> 14709795

Pituitary adenylate cyclase-activating polypeptide does not colocalize with vasoactive intestinal polypeptide in the hypothalamic magnocellular nuclei and posterior pituitary of cats and rats.

Viktoria Vereczki1, Katalin Köves, Zsuzsanna E Tóth, Akemichi Baba, Hitoshi Hashimoto, Kristóf Fógel, Akira Arimura, Mária Kausz.   

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) immunoreactive cells were demonstrated in the hypothalamic magnocellular nuclei in cats and rats. In cats these immunoreactive cells were stained without any treatment or intervention; however, in rats we had to use the pituitary stalk section to enhance the amount of PACAP and VIP for successful immunostaining. In both species the regions occupied by PACAP and VIP immunoreactive cells partially overlap each other in the paraventricular and supraoptic nuclei. Nevertheless, in either cats or rats PACAP and VIP immunoreactivities do not colocalize in the same cells studied by double labeling immunohistochemistry (IHC) or by the combination of immunohistochemistry and in situ hybridization. As was expected, PACAP and VIP immunoreactive materials were stored in different fibers of the posterior pituitary where the distribution of PACAP and VIP fibers also showed different patterns: PACAP fibers form a dense plexus at the periphery of the posterior lobe, in the vicinity of the intermediate lobe; however, the VIP fibers were evenly distributed mainly in the center of the posterior lobe. In spite of the high sequence homology of PACAP and VIP, the two peptides are synthesized in different subpopulations of hypothalamic neurons. This different distribution correlates well with the different role of the hypothalamic PACAP and VIP in the biologic clock and in the functions of the anterior and posterior pituitary.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14709795     DOI: 10.1385/ENDO:22:3:225

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  39 in total

1.  Study on the hypothalamic factors mediating the inhibitory effect of PACAP38 on ovulation.

Authors:  O Kántor; J Molnár; A Heinzlmann; A Arimura; Z Fürst; K Köves
Journal:  Peptides       Date:  2001-12       Impact factor: 3.750

2.  PACAP38 and PACAP27 administered intracerebroventricularly have an opposite effect on LH secretion.

Authors:  O Kántora; J Molnár; A Arimura; K Köves
Journal:  Peptides       Date:  2000-06       Impact factor: 3.750

3.  Dynorphin and vasopressin: common localization in magnocellular neurons.

Authors:  S J Watson; H Akil; W Fischli; A Goldstein; E Zimmerman; G Nilaver; T B van wimersma Griedanus
Journal:  Science       Date:  1982-04-02       Impact factor: 47.728

Review 4.  Effect of the lack of light impulses on the hypothalamic PACAP and C-fos immunoreactivities in rats.

Authors:  K Köves; A Lakatos; A Somogyvári-Vigh; K Fogel; O Kántor; P Gööz; U K Jamali; X Grandier-Vazeille; A Arimura
Journal:  Neurobiology (Bp)       Date:  1997

5.  The distribution of pituitary adenylate cyclase-activating polypeptide-like immunoreactivity is distinct from helodermin- and helospectin-like immunoreactivities in the rat brain.

Authors:  L Kivipelto; A Absood; A Arimura; F Sundler; R Håkanson; P Panula
Journal:  J Chem Neuroanat       Date:  1992 Jan-Feb       Impact factor: 3.052

6.  Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes.

Authors:  A Arimura; A Somogyvári-Vigh; A Miyata; K Mizuno; D H Coy; C Kitada
Journal:  Endocrinology       Date:  1991-11       Impact factor: 4.736

7.  Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide receptor in the rat brain: an in situ hybridization study.

Authors:  H Hashimoto; H Nogi; K Mori; H Ohishi; R Shigemoto; K Yamamoto; T Matsuda; N Mizuno; S Nagata; A Baba
Journal:  J Comp Neurol       Date:  1996-08-05       Impact factor: 3.215

8.  Distribution and ultrastructural localization of pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptor in the rat retina.

Authors:  T Seki; S Shioda; Y Nakai; A Arimura; R Koide
Journal:  Ann N Y Acad Sci       Date:  1998-12-11       Impact factor: 5.691

9.  Pituitary adenylate cyclase activating peptide (PACAP) in the retinohypothalamic tract: a daytime regulator of the biological clock.

Authors:  J Hannibal; J M Ding; D Chen; J Fahrenkrug; P J Larsen; M U Gillette; J D Mikkelsen
Journal:  Ann N Y Acad Sci       Date:  1998-12-11       Impact factor: 5.691

10.  Pituitary adenylate cyclase activating peptide-38 (PACAP-38), PACAP-27, and PACAP related peptide (PRP) in the rat median eminence and pituitary.

Authors:  J D Mikkelsen; J Hannibal; J Fahrenkrug; P J Larsen; J Olcese; C McArdle
Journal:  J Neuroendocrinol       Date:  1995-01       Impact factor: 3.627

View more
  3 in total

Review 1.  Advent and recent advances in research on the role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the regulation of gonadotropic hormone secretion of female rats.

Authors:  Katalin Köves; Orsolya Kántor; András Lakatos; Enikő Szabó; Eszter Kirilly; Andrea Heinzlmann; Flóra Szabó
Journal:  J Mol Neurosci       Date:  2014-04-03       Impact factor: 3.444

Review 2.  Current State of Understanding of the Role of PACAP in the Hypothalamo-Hypophyseal Gonadotropin Functions of Mammals.

Authors:  Katalin Köves; Enikő Szabó; Orsolya Kántor; Andrea Heinzlmann; Flóra Szabó; Ágnes Csáki
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-06       Impact factor: 5.555

3.  Estrogen mediates sex differences in preoptic neuropeptide and pituitary hormone production in medaka.

Authors:  Junpei Yamashita; Yuji Nishiike; Thomas Fleming; Daichi Kayo; Kataaki Okubo
Journal:  Commun Biol       Date:  2021-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.